Compare

Compare archived captures

This view highlights text differences between two archived captures. It does not interpret meaning or provide guidance.

Descriptive changes only

This comparison highlights text changes between archived captures. It does not interpret the change or provide medical advice. For up-to-date recommendations, always consult the official source website.

Need to cite this comparison? See /cite.

Compare to the live pageView snapshot

Earlier capture

Marketed Health Products Directorate - Canada.ca

Apr 18, 2025

legacy-hc-2025-04-21

ID 249919

Original URL ↗
View snapshot

Later capture

Marketed Health Products Directorate - Canada.ca

Jan 1, 2026

hc-20260101

ID 404970

Original URL ↗
View snapshot
updated2 sections changed
2 sections changed0 added0 removed+1 / -4 linesChange ratio: 2%
---
+++
@@ -129,8 +129,6 @@
Ottawa ON K1A 0K9
E-mail:
osip-bppi@hc-sc.gc.ca
-Telephone:
-613-941-7281
Teletypewriter:
1-800-465-7735 (Service Canada)
Cost Recovery (for human drug submissions)
@@ -155,5 +153,4 @@
Canada vigilance adverse reaction online database
Adverse reaction and medical device problem reporting
Page details
-Date modified:
-2024-12-02
+2025-09-05